Novel and classical molecular pathways identified in pituitary tumorigenesis using mRNA profiling

References 1 Lania A, Mantovani G, Spada A. 2012. cAMP pathway and pituitary tumorigenesis. Ann Endocrinol (Paris). 73(2), 73-75. 2 Elston MS, Gill AJ, Conaglen JV, Clarkson A, Shaw JM, Law AJ, Cook RJ, Little NS, Clifton-Bligh RJ, Robinson BG, McDonald KL. 2008. Wnt pathway inhibitors are strongly down-regulated in pituitary tumours. 3 Rubinfeld H, Shimon I. 2012. PI3K/Akt/mTOR and Raf/MEK/ERK signalling pathway perturbations in non-functioning pituitary adenomas. Endocrine. 42(2), 285-291. The Research was funded by the UoM Research Fund Committee Allocation (PHBRP07-02) and Faculty of Medicine and Surgery funds (MDSIN08-22) To identify novel molecular pathways involved in pituitary tumorigenesis using mRNA expression profiles.